Bio-Connect
IHC-P analysis of human prostate carcinoma tissue using GTX28682 Prostatic Acid Phosphatase antibody [PASE/4LJ].
IHC-P analysis of human prostate carcinoma tissue using GTX28682 Prostatic Acid Phosphatase antibody [PASE/4LJ].
IHC-P analysis of human prostate carcinoma tissue using GTX28682 Prostatic Acid Phosphatase antibody [PASE/4LJ].

Prostatic Acid Phosphatase antibody [PASE-4LJ]

GTX28682
GeneTex
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetACP3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Prostatic Acid Phosphatase antibody [PASE-4LJ]
  • Delivery Days Customer
    9
  • Application Supplier Note
    IHC-P: 1:25-1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    PASE-4LJ
  • Conjugate
    Unconjugated
  • Gene ID55
  • Target name
    ACP3
  • Target description
    acid phosphatase 3
  • Target synonyms
    5'-NT, ACP-3, ACPP, TM-PAP, prostatic acid phosphatase, TMPase, acid phosphatase, prostate, ecto-5'-nucleotidase, prostatic acid phosphotase, protein tyrosine phosphatase ACP3, thiamine monophosphatase
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP15309
  • Protein Name
    Prostatic acid phosphatase
  • Scientific Description
    This gene encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. An alternatively spliced transcript variant encoding a longer isoform has been found for this gene. This isoform contains a transmembrane domain and is localized in the plasma membrane-endosomal-lysosomal pathway. [provided by RefSeq, Sep 2008]
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Gan Q, Joseph CT, Guo M, et al. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol. 2019,152(4):495-501. doi: 10.1093/ajcp/aqz063
    Read this paper
  • Yang RK, Zhao P, Lu C, et al. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas. Hum Pathol. 2019,84:173-182. doi: 10.1016/j.humpath.2018.09.009
    Read this paper
  • Giedl J, Büttner-Herold M, Wach S, et al. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma. Hum Pathol. 2016,55:101-7. doi: 10.1016/j.humpath.2016.04.016
    Read this paper
  • Bastaki JM, Purgina BM, Dacic S, et al. Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors. Head Neck Pathol. 2014,8(3):250-60. doi: 10.1007/s12105-014-0518-8
    Read this paper
  • Pistone G, Pistone A, Aricò M, et al. Multiple cutaneous metastases in the chest from prostatic carcinoma. Case Rep Dermatol. 2013,5(1):27-30. doi: 10.1159/000346801
    Read this paper